Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance-Reference-Cited by-同舟云学术

Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance

Published:2006-06 Issue:6 Volume:36 Page:1374-1385
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Anderson Per O.,Manzo Barbara A.,Sundstedt Anette,Minaee Sophie,Symonds Alistair,Khalid Sabah,Rodriguez-Cabezas Maria E.,Nicolson Kirsty,Li Suling,Wraith David C.,Wang Ping

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. Oral Tolerance: Mechanisms and Therapeutic Applications

2. Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune Encephalomyelitis

3. Peptide-based therapeutic vaccines for allergic and autoimmune diseases

4. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

5. In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tolerance-inducing therapies in coeliac disease — mechanisms, progress and future directions;Nature Reviews Gastroenterology & Hepatology;2024-02-09

2. Repetitive Antigen Responses of LDL-Reactive CD4+ T Cells Induce Tr1 Cell–Mediated Immune Tolerance;Arteriosclerosis, Thrombosis, and Vascular Biology;2023-08

3. The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia;iScience;2022-07

4. The Immune Checkpoint ICOSLG is a Relapse-Predicting Biomarker and Therapeutic Target in Infant t(4;11) Acute Lymphoblastic Leukemia;SSRN Electronic Journal;2022

5. Antigen-specific immunotherapy with apitopes suppresses generation of FVIII inhibitor antibodies in HLA-transgenic mice;Blood Advances;2021-09-16